Recruitment of effector lymphocytes by initiator lymphocytes: recruited lymphocytes are immunospecific

Association of Sphingosine-1-phosphate (S1P)/S1P Receptor-1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma.

Journal of veterinary internal medicine·2015

Vaccination against autoimmune disease with lines of autoimmune T lymphocytes.

Immunology today·2014

The advantage of being a low responder.

Immunology today·2014

Natural autoantibodies might prevent autoimmune disease.

Immunology today·2014

Antigen microarrays identify CNS-produced autoantibodies in RRMS.

Neurology·2012

Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes.

Clinical and experimental immunology·2008

The Emergent Architecture of Autonomous Clocks Described by Computational Algorithms of Regulatory Networks.

Advances in experimental medicine and biology·2026

Physical Frameworks and Theories on How Autonomous Biological Oscillators Synchronize.

Advances in experimental medicine and biology·2026

Leveraging Autonomous Biological Oscillators for Directed Evolution of Switchable Proteins.

Advances in experimental medicine and biology·2026

Synthetic Cell-Based Approaches to Dissect Autonomous Cellular Oscillators: Recent Applications on the Cell Cycle.

Advances in experimental medicine and biology·2026

Autonomous Oscillations of NF-κB.

Advances in experimental medicine and biology·2026

An Autonomous Clock that Controls Genetic Information Flow and Cellular Proteostasis.

Advances in experimental medicine and biology·2026

IL-12-producing iPSC-derived antigen-presenting cells enhance antitumor immunity and enable off-the-shelf immunotherapy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Targeting myeloid cell plasticity and metabolic reprogramming to alleviate T cell dysfunction and exhaustion-associated states and enhance immune checkpoint blockade therapy.

Biomarker research·2026

Cardiovascular Toxicities of Contemporary Cancer Immunotherapies: A Narrative Review of Immune Checkpoint Inhibitors, Bispecific T-Cell Engagers, and CAR-T Cell Therapies.

Clinical lymphoma, myeloma & leukemia·2026

Extracardiovascular immune-related adverse events in patients with suspected cardiac toxicity associated with immune checkpoint inhibitors.

La Revue de medecine interne·2026

Prospective phase I study of nivolumab to promote graft-versus-tumour in relapsed or refractory haematological malignancy post allogeneic haematopoietic stem cell transplantation.

British journal of haematology·2026

REG family proteins and immune regulation: current evidence and perspectives.

Biochemical and biophysical research communications·2026

Related Experiment Videos

Recruitment of effector lymphocytes by initiator lymphocytes: recruited lymphocytes are immunospecific

Related Concept Videos

Association of Sphingosine-1-phosphate (S1P)/S1P Receptor-1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma.

Vaccination against autoimmune disease with lines of autoimmune T lymphocytes.

The advantage of being a low responder.

Natural autoantibodies might prevent autoimmune disease.

Antigen microarrays identify CNS-produced autoantibodies in RRMS.

Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes.

The Emergent Architecture of Autonomous Clocks Described by Computational Algorithms of Regulatory Networks.

Physical Frameworks and Theories on How Autonomous Biological Oscillators Synchronize.

Leveraging Autonomous Biological Oscillators for Directed Evolution of Switchable Proteins.

Synthetic Cell-Based Approaches to Dissect Autonomous Cellular Oscillators: Recent Applications on the Cell Cycle.

Autonomous Oscillations of NF-κB.

An Autonomous Clock that Controls Genetic Information Flow and Cellular Proteostasis.

IL-12-producing iPSC-derived antigen-presenting cells enhance antitumor immunity and enable off-the-shelf immunotherapy.

Targeting myeloid cell plasticity and metabolic reprogramming to alleviate T cell dysfunction and exhaustion-associated states and enhance immune checkpoint blockade therapy.

Cardiovascular Toxicities of Contemporary Cancer Immunotherapies: A Narrative Review of Immune Checkpoint Inhibitors, Bispecific T-Cell Engagers, and CAR-T Cell Therapies.

Extracardiovascular immune-related adverse events in patients with suspected cardiac toxicity associated with immune checkpoint inhibitors.

Prospective phase I study of nivolumab to promote graft-versus-tumour in relapsed or refractory haematological malignancy post allogeneic haematopoietic stem cell transplantation.

REG family proteins and immune regulation: current evidence and perspectives.

Related Experiment Videos

Recruitment of effector lymphocytes by initiator lymphocytes: recruited lymphocytes are immunospecific

Related Concept Videos

Related Articles